Galectin Therapeutics reported $-2.71M in Interest Income for its fiscal quarter ending in December of 2023.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Gilead Sciences USD 95M 0 Mar/2026
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 38.12M 4.43M Jun/2026
Merck USD 35M 34M Mar/2026